| Overview |
| bsm-61396r-pe-cy5 |
| Parkin Recombinant Antibody, PE-Cy5 Conjugated |
| WB, FCM |
| Human, Mouse, Rat |
| Specifications |
| PE-Cy5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Parkin |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 5071 |
| O60260 |
| Cytoplasm, Nucleus, Cell membrane |
| AR-JP; LPRS2; PARK2; parkin; parkin 2; PDJ; PRKN; PRKN2. |
| Functions within a multiprotein E3 ubiquitin ligase complex, catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins. |
| Application Dilution |
| WB |
1:500-2000 |
| FCM |
FCM1:50-100 |
Powered by Bioz